References
- Osterman MJK, Hamilton BE, Martin JA, et al. Births: final data for 2020. Natl Vital Stat Rep. 2021;70(17):1–50.
- Fell DB, Joseph K. Temporal trends in the frequency of twins and higher-order multiple births in Canada and the United States. BMC Pregnancy Childbirth. 2012;12:103. doi:10.1186/1471-2393-12-103.
- Kulkarni AD, Jamieson DJ, Jones HW, et al. Fertility treatments and multiple births in the United States. N Engl J Med. 2013;369(23):2218–2225. doi:10.1056/NEJMoa1301467.
- Adashi EY, Gutman R. Delayed childbearing as a growing, previously unrecognized contributor to the national plural birth excess. Obstet Gynecol. 2018;132(4):999–1006. doi:10.1097/AOG.0000000000002853.
- Nylander PP. The factors that influence twinning rates. Acta Genet Med Gemellol . 1981;30(3):189–202. doi:10.1017/s0001566000007650.
- Martin JA, Hamilton BE, Osterman MJK, et al. Births: final data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51.
- Misra DP, Ananth CV. Infant mortality among singletons and twins in the United States during 2 decades: effects of maternal age so pediatrics. Pediatrics. 2002;110(6):1163–1168. doi:10.1542/peds.110.6.1163.
- Madar H, Goffinet F, Seco A, et al. Severe acute maternal morbidity in twin compared with singleton pregnancies. Obstet Gynecol. 2019;133(6):1141–1150. doi:10.1097/AOG.0000000000003261.
- Barrett JF, Hannah ME, Hutton EK, et al. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med. 2013;369(14):1295–1305. doi:10.1056/NEJMoa1214939.
- Gezer A, Rashidova M, Güralp O, et al. Perinatal mortality and morbidity in twin pregnancies: the relation between chorionicity and gestational age at birth. Arch Gynecol Obstet. 2012;285(2):353–360. doi:10.1007/s00404-011-1973-z.
- Fox NS, Rebarber A, Klauser CK, et al. Intrauterine growth restriction in twin pregnancies: incidence and associated risk factors. Am J Perinatol. 2011;28(4):267–272. doi:10.1055/s-0030-1270116.
- Benkő Z, Syngelaki A, Nicolaides KH, et al. Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy. Ultrasound Obstet Gynecol. 2017;50(1):88–92. doi:10.1002/uog.17470.
- Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol. 2000;182(4):938–942. doi:10.1016/s0002-9378(00)70350-4.
- Brown MA, Hall DR, Gupte S, et al. The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–169. doi:10.1016/j.preghy.2021.09.008.
- Romero R, Lockwood C, Oyarzun E, et al. Toxemia: new concepts in an old disease. Semin Perinatol. 1988;12(4):302–323.
- B, Dekker G, Kupferminc M, et al. Pre-eclampsia. Lancet. 2005;365(9461):785–799. doi:10.1016/S0140-6736(05)71003-5.
- Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137. doi:10.1053/j.semperi.2009.02.010.
- Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1–544.e12. e1doi:10.1016/j.ajog.2013.08.019.
- ACOG practice bulletin no. 204: fetal growth restriction. Medicine. American college of obstetricians and gynecologists’ committee on practice bulletins – obstetrics and the society for maternal-fetal. Obstet Gynecol. 2019;133(2):e97–109.
- Liu J, Wang XF, Wang Y, et al. The incidence rate, high-risk factors, and short- and long-term adverse outcomes of fetal growth restriction: a report from Mainland China. Medicine . 2014;93(27):e210. doi:10.1097/MD.0000000000000210.
- Chauhan SP, Shields D, Parker D, et al. Detecting fetal growth restriction or discordant growth in twin gestations stratified by placental chorionicity. J Reprod Med. 2004;49(4):279–284.
- Curado J, Sileo F, Bhide A, et al. Early- and late-onset selective fetal growth restriction in monochorionic diamniotic twin pregnancy: natural history and diagnostic criteria. Ultrasound Obstet Gynecol. 2020;55(5):661–666. doi:10.1002/uog.20849.
- Fick AL, Feldstein VA, Norton ME, et al. Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins. Am J Obstet Gynecol. 2006;195(1):178–183. doi:10.1016/j.ajog.2006.01.015.
- Chauhan SP, Scardo JA, Hayes E, et al. Twins: prevalence, problems, and preterm births. T Am J Obstet Gynecol. s.l.: Epub. 2010;203(4):305–315. doi:10.1016/j.ajog.2010.04.031.
- Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480. doi:10.1038/nrneph.2014.102.
- Herraiz I, Llurba E, Verlohren S, et al. Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies. Fetal Diagn Ther. 2018;43(2):81–89. doi:10.1159/000477903.
- Sovio U, Gaccioli F, Cook E, et al. Slowing of fetal growth and elevated maternal serum sFLT1: PlGF are associated with early term spontaneous labor. Am J Obstet Gynecol. 2021;225(5):520.e1–520.e10. e1doi:10.1016/j.ajog.2021.04.232.
- Barton JR, Woelkers DA, Newman RB, et al. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study. Am J Obstet Gynecol. 2020;222(3):259.e1–259.e11. doi:10.1016/j.ajog.2019.09.003.
- Herraiz I, Quezada MS, Rodriguez-Calvo J, et al. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Ultrasound Obstet Gynecol. 2018;52(5):631–638. doi:10.1002/uog.18894.
- Allen RE, Rogozinska E, Cleverly K, et al. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;182:194–201. doi:10.1016/j.ejogrb.2014.09.027.
- Gaccioli F, Aye ILMH, Sovio U, et al. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. Am J Obstet Gynecol. 2018; 218(2S):S725–S737. doi:10.1016/j.ajog.2017.12.002.
- Friedman AM, Cleary KL. Prediction and prevention of ischemic placental disease. Semin Perinatol. 2014;38(3):177–182. doi:10.1053/j.semperi.2014.03.002.
- Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683. doi:10.1056/NEJMoa031884.
- Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658. doi:10.1172/JCI17189.
- Maynard SE, Venkatesha S, Thadhani R, et al. Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005;57(5 Pt 2):1R–7R. doi:10.1203/01.PDR.0000159567.85157.B7.
- Agrawal S, Shinar S, Cerdeira AS, et al. Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis. Hypertension. 2019;74(5):1124–1135. doi:10.1161/HYPERTENSIONAHA.119.13360.
- Martínez-Varea A, Martínez-Sáez C, Domenech J, et al. sFlt-1/PlGF ratio at 24 weeks gestation in twin pregnancies as a predictor of preeclampsia or fetal growth restriction. Fetal Diagn Ther. 2022;49(4):206–214. doi:10.1159/000525169.
- Faupel-Badger JM, McElrath TF, Lauria M, et al. Maternal circulating angiogenic factors in twin and singleton pregnancies. Am J Obstet Gynecol. 2015;212(5):636.e1–636–e8. doi:10.1016/j.ajog.2014.11.035.
- De La Calle M, Delgado JL, Verlohren S, et al. Gestational age-specific reference ranges for the sFlt-1/PlGF immunoassay ratio in twin pregnancies. Fetal Diagn Ther. 2021;48(4):288–296. doi:10.1159/000514378.
- Hoffmann J, Ossada V, Weber M, et al. An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome. Pregnancy Hypertens. 2017;10:165–170. doi:10.1016/j.preghy.2017.08.003.
- Rana S, Hacker MR, Modest AM, et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012;60(2):451–458. doi:10.1161/HYPERTENSIONAHA.112.195065.
- Karge A, Seiler A, Flechsenhar S, et al. Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio. Pregnancy Hypertens. 2021;24:37–43. doi:10.1016/j.preghy.2021.02.003.
- Saleh L, Tahitu SIM, Danser AHJ, et al. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies. Pregnancy Hypertens. 2018;14:222–227. doi:10.1016/j.preghy.2018.03.014.
- Binder J, Palmrich P, Pateisky P, et al. The prognostic value of angiogenic markers in twin pregnancies to predict delivery due to maternal complications of preeclampsia. Hypertension. 2020;76(1):176–183. doi:10.1161/HYPERTENSIONAHA.120.14957.
- Dröge L, Herraìz I, Zeisler H, et al. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies. Ultrasound Obstet Gynecol. 2015;45(3):286–293. doi:10.1002/uog.14760.
- Choi R, Park M, Oh Y, et al. Preeclampsia screening using the ratio of soluble FMS-like tyrosine kinase-1 to placental growth factor during pregnancy in pregnant Korean women. Clin Lab. 2020;66(09/2020):1893–1898. doi:10.7754/Clin.Lab.2020.200117.
- Shinohara S, Sunami R, Kasai M, et al. Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study. Hypertens Pregnancy. 2021;40(4):330–335. doi:10.1080/10641955.2021.1987455.
- Krotz S, Fajardo J, Ghandi S, et al. Hypertensive disease in twin pregnancies: a review. Twin Res. 2002;5(1):8–14. doi:10.1375/twin.5.1.8.
- Narang K, Szymanski LM. Multiple gestations and hypertensive disorders of pregnancy: what do we know? Curr Hypertens Rep. 2020;23(1):1. doi:10.1007/s11906-020-01107-4.
- Grantz KL, Grewal J, Albert PS, et al. Dichorionic twin trajectories: the NICHD fetal growth studies. Am J Obstet Gynecol. 2016;215(2):221.e1–221.e16. e1doi:10.1016/j.ajog.2016.04.044.
- Rao A, Sairam S, Shehata H. Obstetric complications of twin pregnancies. Best Pract Res Clin Obstet Gynaecol. 2004;18(4):557–576. doi:10.1016/j.bpobgyn.2004.04.007.
- Stepan H, Galindo A, Hund M, et al. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61(2):168–180. doi:10.1002/uog.26032.